{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Switchpoint Bio raises €4.75 million for blood-based drug response platform","author_name":"techandbusiness.org · Startups","thumbnail_url":"https://www.eu-startups.com/wp-content/uploads/2026/11/Screenshot-2026-11-11-at-1.41.17-PM-1024x739.png","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Startups</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/txEZGf6noj2TDN39hRbG4v\" style=\"color:#fff;text-decoration:none;\">Switchpoint Bio raises €4.75 million for blood-based drug response platform</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Switchpoint Bio has raised €4.75 million ($5.3 million) in pre-Seed financing to develop its blood-based platform for studying disease and treatment response, EU-Startups reports.</p>\n    </blockquote>"}